A detailed history of Caisse De Depot Et Placement Du Quebec transactions in Eli Lilly & CO stock. As of the latest transaction made, Caisse De Depot Et Placement Du Quebec holds 679,796 shares of LLY stock, worth $512 Million. This represents 1.2% of its overall portfolio holdings.

Number of Shares
679,796
Previous 685,863 0.88%
Holding current value
$512 Million
Previous $621 Million 3.01%
% of portfolio
1.2%
Previous 1.51%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$772.14 - $960.02 $4.68 Million - $5.82 Million
-6,067 Reduced 0.88%
679,796 $602 Million
Q2 2024

Aug 14, 2024

SELL
$724.87 - $909.04 $15.6 Million - $19.5 Million
-21,505 Reduced 3.04%
685,863 $621 Million
Q1 2024

May 14, 2024

BUY
$592.2 - $792.28 $80.2 Million - $107 Million
135,354 Added 23.66%
707,368 $550 Million
Q4 2023

Feb 14, 2024

BUY
$525.19 - $619.13 $28.3 Million - $33.4 Million
53,945 Added 10.41%
572,014 $333 Million
Q3 2023

Nov 14, 2023

SELL
$434.7 - $599.3 $24.7 Million - $34.1 Million
-56,862 Reduced 9.89%
518,069 $278 Million
Q2 2023

Aug 14, 2023

BUY
$350.74 - $468.98 $24.7 Million - $33.1 Million
70,477 Added 13.97%
574,931 $270 Million
Q1 2023

May 12, 2023

SELL
$310.63 - $364.82 $31 Million - $36.5 Million
-99,948 Reduced 16.54%
504,454 $173 Million
Q4 2022

Feb 14, 2023

SELL
$321.55 - $374.67 $18.8 Million - $21.9 Million
-58,552 Reduced 8.83%
604,402 $221 Million
Q3 2022

Nov 14, 2022

BUY
$296.48 - $337.87 $90.6 Million - $103 Million
305,463 Added 85.45%
662,954 $214 Million
Q2 2022

Aug 12, 2022

BUY
$278.73 - $327.27 $30.3 Million - $35.6 Million
108,875 Added 43.79%
357,491 $116 Million
Q1 2022

May 13, 2022

SELL
$234.69 - $291.66 $1.53 Million - $1.9 Million
-6,500 Reduced 2.55%
248,616 $71.2 Million
Q4 2021

Feb 14, 2022

BUY
$224.85 - $279.04 $16.4 Million - $20.3 Million
72,900 Added 40.01%
255,116 $70.5 Million
Q3 2021

Nov 12, 2021

BUY
$221.6 - $272.71 $4.03 Million - $4.96 Million
18,200 Added 11.1%
182,216 $42.1 Million
Q2 2021

Aug 13, 2021

BUY
$180.55 - $233.54 $4.9 Million - $6.34 Million
27,143 Added 19.83%
164,016 $37.6 Million
Q1 2021

May 14, 2021

BUY
$164.32 - $212.72 $7.84 Million - $10.1 Million
47,713 Added 53.51%
136,873 $25.6 Million
Q4 2020

Feb 12, 2021

SELL
$130.46 - $172.63 $3.46 Million - $4.57 Million
-26,497 Reduced 22.91%
89,160 $15.1 Million
Q3 2020

Nov 13, 2020

SELL
$146.22 - $169.13 $818,832 - $947,128
-5,600 Reduced 4.62%
115,657 $17.1 Million
Q2 2020

Aug 14, 2020

BUY
$136.42 - $164.18 $8.65 Million - $10.4 Million
63,400 Added 109.58%
121,257 $19.9 Million
Q1 2020

May 14, 2020

SELL
$119.05 - $147.35 $864,183 - $1.07 Million
-7,259 Reduced 11.15%
57,857 $8.03 Million
Q4 2019

Feb 14, 2020

SELL
$106.92 - $132.43 $10.8 Million - $13.4 Million
-101,398 Reduced 60.89%
65,116 $8.56 Million
Q3 2019

Nov 14, 2019

BUY
$106.79 - $116.16 $2.35 Million - $2.56 Million
22,029 Added 15.25%
166,514 $18.6 Million
Q2 2019

Aug 09, 2019

SELL
$110.79 - $129.32 $3.45 Million - $4.02 Million
-31,100 Reduced 17.71%
144,485 $16 Million
Q1 2019

May 14, 2019

SELL
$111.31 - $131.02 $23.9 Million - $28.1 Million
-214,615 Reduced 55.0%
175,585 $22.8 Million
Q4 2018

Feb 14, 2019

BUY
$105.9 - $118.64 $5.3 Million - $5.93 Million
50,000 Added 14.7%
390,200 $45.2 Million
Q1 2018

May 14, 2018

SELL
$74.21 - $87.6 $422,996 - $499,319
-5,700 Reduced 1.65%
340,200 $26.3 Million
Q4 2017

Feb 13, 2018

SELL
$81.94 - $87.89 $3.96 Million - $4.25 Million
-48,300 Reduced 12.25%
345,900 $29.2 Million
Q3 2017

Nov 13, 2017

BUY
$77.07 - $85.54 $30.4 Million - $33.7 Million
394,200
394,200 $33.9 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $716B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Caisse De Depot Et Placement Du Quebec Portfolio

Follow Caisse De Depot Et Placement Du Quebec and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Caisse De Depot Et Placement Du Quebec, based on Form 13F filings with the SEC.

News

Stay updated on Caisse De Depot Et Placement Du Quebec with notifications on news.